WHO launches clinical trial for new Ebola treatment in DR Congo

Progressive: Progressive-leaning outlets emphasize the clinical trial launch and international scientific coordination as the primary response to the epidemic, focusing on research institutions and partnerships.

Moderate: Centrist outlets report both the epidemic's death toll and humanitarian strain, warning that the crisis could overwhelm existing aid programs supporting affected communities.

Conservative: Conservative-leaning outlets highlight the trial as a medical milestone, while also reporting on security threats to health infrastructure and social breakdown in affected areas.